"S2-2 STRATEGIC PROPOSALS TO AVOID DRUG INTERACTIONS DURING DRUG DEVELOPMENT : A LESSON FROM A TERFENADINE-RELATED DRUG INTERACTION (<SYMPOSIUM 2>Strategy how we can learn drug-drug interaction during the development of a new drug)
Author's Organization:Chairman, Department of Clinical Pharmacology, Research Institute, International Medical Center of Japan Chairman, Department of Clinical Pharmacology, Research Institute, International Medical Center of Japan